Advanced search
Publication Cover
Emerging Microbes & Infections Volume 13, 2024 - Issue 1
Submit an article Journal homepage
2,125
Views
0
CrossRef citations to date
0
Altmetric
Drug Resistance and Novel Antimicrobial Agents

Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition

Peng Hea Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Sijing Huanga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Rui Wanga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Yunkai Yanga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Shangye Yanga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Yue Wanga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Mengya Qia Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Jiyang Lia Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
,
Xiaofen Liub Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Xuyao Zhanga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaView further author information
&
Meiqing Fenga Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2294854 | Received 04 Sep 2023, Accepted 11 Dec 2023, Published online: 30 Jan 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.